Four human FANCG polymorphic variants show normal biological function in hamster CHO cells

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Fanconi anemia (FA) is a rare genetic disorder characterized by bone marrow failure and a high risk of cancer.
• Mutations in at least 12 FA genes, which encode proteins crucial for DNA repair and genomic stability, cause FA.
• The functional impact of FANCG gene variants identified in the general population on cancer susceptibility remains largely unknown.

Purpose of the Study:

• To investigate the functional consequences of common FANCG gene polymorphisms.
• To determine if these variants affect DNA repair pathways relevant to Fanconi anemia.
• To establish a functional assay for assessing FANCG variant activity.

Main Methods:

• Constructed plasmids encoding four common FANCG polymorphisms.
• Transfected these plasmids into Fancg-deficient hamster cells (KO40 line).
• Assessed cellular resistance to mitomycin C (MMC) and Fancd2 monoubiquitination as indicators of FA pathway functionality.

Main Results:

• All four examined FANCG polymorphic variants restored cellular resistance to MMC and Fancd2 monoubiquitination in Fancg-deficient cells.
• These functional restoration levels were comparable to those observed with wild-type FANCG.
• A known disease-causing mutant (L71P) failed to complement the Fancg deficiency, validating the assay.

Conclusions:

• Common FANCG polymorphic variants found in the human population do not appear to impair FANCG protein function.
• These variants do not seem to compromise the DNA repair mechanisms associated with Fanconi anemia.
• The developed assay system provides a sensitive method for evaluating FANCG variant functionality.